Table 2. Analgesic Activity of Thiowurtzine in the Hot Plate Test in Outbred Male Stock CD Rats (X ± m)a.
group | pain response latency, s | pain response inhibition, % |
---|---|---|
Series I: Drug Administration for 4 days | ||
(1) negative control—vehicle (n = 8) | 9.8 ± 1.0 | |
(2) diclofenac, 5 mg/kg (n = 9) | 10.9 ± 1.5 | 11.3 |
(3) thiowurtzine, 25 mg/kg (n = 9) | 10.4 ± 1.3 | 6.1 |
(4) thiowurtzine, 50 mg/kg (n = 8) | 12.1 ± 1.6 | 23.5 |
Series II: Drug Administration for 4 days | ||
(1) negative control—vehicle (n = 10) | 11.3 ± 1.0 | |
(2) thiowurtzine, 100 mg/kg (n = 10) | 20.1 ± 2.3, **(1–2) | 77.9 |
(3) thiowurtzine, 200 mg/kg (n = 10) | 14.9 ± 2.1, *(2–3) | 31.9 |
(4) thiowurtzine, 300 mg/kg (n = 10) | 13.2 ± 2.7 | 16.8 |
*p < 0.05, **p < 0.01 compared to the negative control and the reference group (Mann–Whitney U test).